Dev

Évaluation des capacités de conduite automobile en situation écologique chez les sujets âgés atteints de maladie d’Alzheimer au stade léger et modéré. Assessment of driving capabilities in an eco-friendly environment in elderly patients with mild to moderate Alzheimer’s disease. Investments…

Etude de l’effet de la stimulation électrique du noyau basal de Meynert sur les troubles cognitivo-comportementaux des patients atteints de la démence à corps de Lewy. Etude DEMENSTIM. Study of the effect of electrical stimulation of the Meynert basal nucleus…

Etiologie et physiopathologie des syndromes parkinsoniens en région Caraïbe. Etiology and physiopathology of parkinsonian syndromes in the Caribbean region. Investments < €500k France 2016    

Does a monitoring deficit underly the real world/laboratory prospective memory paradox in healthy and pathological aging? Investments < €500k France 2016    

3D in-line blood brain barrier pharmacology testing platform Investments < €500k France 2016    

Study of the association of microRNA and mitochondria and their role in regulation of neuronal cell death in Fragile X Tremor Ataxia Syndrome (FXTAS) Investments < €500k France 2016    

Statistical Models for Alzheimer’s disease and Aging Investments < €500k France 2016    

Validation of MT5-MMP as a new therapeutic target in Alzheimer’s disease and mechanisms of action Investments < €500k France 2016    

Legal, philosophical and social issues in neurosciences: the deep brain stimulation case Investments < €500k France 2016    

Refining the bioactivity of P42, a hit therapeutic peptide, and developing a combined therapeutic peptide approach for treating Huntington’s Disease. Investments < €500k France 2016